Skip to main content
. 2024 Jun 6;14(11):1195. doi: 10.3390/diagnostics14111195

Figure 4.

Figure 4

(A) Recurrence-free survival according to cytoplasmatic CXCR4 expression in post-neoadjuvant surgical samples from patients with synovial sarcoma. (B) Overall survival according to cytoplasmatic CXCR4 expression in post-neoadjuvant surgical samples obtained from patients with synovial sarcoma.